Status:
COMPLETED
Preoperative Combined Radiation and Chemotherapy - Rectal Cancer
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Rectal Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
There is no established standard preoperative treatment in rectal cancer. Two large randomized studies in North America closed from lack of accrual; therefore the only method of assessing preoperative...
Eligibility Criteria
Inclusion
- Biopsy proven adenocarcinoma of the rectum
- Performance status \<2 (ECOG, appendix II)
- Clinical Stage T2 N1-2, T3-4 NO-2, without evidence of distant metastasis
Exclusion
- Prior pelvic irradiation
- Inflammatory bowel disease
- Evidence of distant metastasis
- Performance status \>2
Key Trial Info
Start Date :
March 1 2001
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00232453
Start Date
March 1 2001
End Date
December 1 2004
Last Update
February 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9